Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection

As of 2021 November 29, booster vaccination against SARS-CoV-2 infection has been recommended for all individuals aged 18 years and older in the United States. A key reason for this recommendation is the expectation that a booster vaccine dose can alleviate observed waning of vaccine effectiveness (...

Descripción completa

Detalles Bibliográficos
Autores principales: Niesen, Michiel J M, Matson, Robert, Puranik, Arjun, O'Horo, John C, Pawlowski, Colin, Vachon, Celine, Challener, Douglas, Virk, Abinash, Swift, Melanie, Speicher, Leigh, Gordon, Joel, Geyer, Holly, Lenehan, Patrick J, Venkatakrishnan, A J, Soundararajan, Venky, Badley, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Biological, Health, and Medical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802350/
https://www.ncbi.nlm.nih.gov/pubmed/36713312
http://dx.doi.org/10.1093/pnasnexus/pgac042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802350/
https://www.ncbi.nlm.nih.gov/pubmed/36713312
http://dx.doi.org/10.1093/pnasnexus/pgac042

Ejemplares similares